中文

尔康制药 Revenue Breakdown

Period 2026-03-31 ・ Reported 2026-04-24
ItemAmountY/Y
Revenue¥0.25B-30.0%
Gross profit¥0.07B
Operating income¥0.01B
Net income¥0.01B-60.6%
Gross margin28.4%Net margin 3.8%
Revenue Q/Q+55.3%

Revenue Segments

The filing did not disclose a revenue breakdown for this period.

Costs & Expenses

ItemAmount% of revenue
Cost of revenue¥0.18B71.6%
R&D¥0.01B3.6%
SG&A¥0.05B20.9%
Tax & other¥0.00B0.3%
Generate the full Sankey chart →

The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.

Other companies

佳沃食品联建光电中威电子华宇软件开能健康梅安森三丰智能汽轮科技华昌达和晶科技金明精机温州宏丰

Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies